Ecolab (ECL)
NYSE: ECL · Specialty Chemicals · Saint Paul, MN
Our rating: Neutral
Neutral reaffirmed at $302.98, moderate conviction, October 30, 2026.
Breaks if: The Neutral view turns Positive if revenue growth reaccelerates above 5% year over year and FCF margin expands above 14% across the next two quarterly filings — that combination would signal the multiple is earning its keep. It turns Cautious if reported revenue growth goes flat or negative in the next quarterly filing, or if free cash flow falls below $1.4B on a trailing-twelve-month basis within the next two prints — either would confirm the current price reflects no plausible near-term trajectory.
Key figures
| Market value | $82.7B |
|---|---|
| Revenue, last 12 months | $17.4B |
| Net income, last 12 months | $2.1B |
| Free cash flow, last 12 months | $1.8B |
| Price to earnings | 39.7× |
| Free cash flow yield | 2.2% |
| Dividend yield | 1.0% |
| Operating margin | 16.7% |
| Return on equity | 20.7% |
| Beta to the S&P 500 | 0.54 |
| Volatility, annualized | 20.8% |
Reported quarters
| Quarter ending | Revenue | Year on year | Earnings per share | Free cash flow |
|---|---|---|---|---|
| September 30, 2026 | $4.7B | 12.7% | $1.95 | $450M |
| June 30, 2026 | $4.4B | 9.7% | $1.90 | $489M |
| March 31, 2026 | $4.1B | 10.0% | $1.52 | $97M |
| December 31, 2025 | $4.2B | 4.8% | $1.98 | $758M |
| September 30, 2025 | $4.2B | 4.2% | $2.05 | $530M |
| June 30, 2025 | $4.0B | 1.0% | $1.84 | $485M |
| March 31, 2025 | $3.7B | −1.5% | $1.41 | $132M |
| December 31, 2024 | $4.0B | 1.7% | $1.66 | $407M |
Three-model forecasts for the next quarter
Written November 21, 2026, before the report. Each settles from the SEC filing.
- Revenue for the quarter is at least $4.59B: Claude 72%, Gemini 95%, Mistral 90%
- Diluted earnings per share are at least $1.98: Claude 58%, Gemini 40%, Mistral 65%
- Free cash flow for the quarter is at least $0.76B: Claude 45%, Gemini 25%, Mistral 40%
11 ledger entries and 37 corporate events on record. Share price as of November 20, 2026. Research and education only. Not investment advice. Stoquity does not manage money or know your circumstances. Ratings, forecasts and lists are produced by software and AI models and can be wrong. Performance figures are hypothetical, measured on paper against a benchmark, and say nothing certain about the future.